Trial Information

Official Title: A Multicenter, Randomized, Controlled Study To Evaluate The Efficacy And Safety Of Short-Term Plasma Exchange Followed By Long-Term Plasmapheresis With Human Albumin Combined With Intravenous Immunoglobulin In Patients With Mild-Moderate AD

Summary

The purpose of this study is to evaluate the changes in the cognitive, functional, behavioral and global domains based on the different applicable psychometric batteries and scales.

Phase: Phase 3

Sponsor: Instituto Grifols, S.A.

Overall Contacts:

Paul J. Pinciaro, PhD
+1-410-814-7617
paul.pinciaro@grifols.com